3
|
Khan A, Akhtar N, Kamran S, Ponirakis G, Petropoulos IN, Tunio NA, Dargham SR, Imam Y, Sartaj F, Parray A, Bourke P, Khan R, Santos M, Joseph S, Shuaib A, Malik RA. Corneal Confocal Microscopy Detects Corneal Nerve Damage in Patients Admitted With Acute Ischemic Stroke. Stroke 2017; 48:3012-3018. [PMID: 29018135 DOI: 10.1161/strokeaha.117.018289] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2017] [Revised: 09/06/2017] [Accepted: 09/13/2017] [Indexed: 12/13/2022]
Abstract
BACKGROUND AND PURPOSE Corneal confocal microscopy can identify corneal nerve damage in patients with peripheral and central neurodegeneration. However, the use of corneal confocal microscopy in patients presenting with acute ischemic stroke is unknown. METHODS One hundred thirty patients (57 without diabetes mellitus [normal glucose tolerance], 32 with impaired glucose tolerance, and 41 with type 2 diabetes mellitus) admitted with acute ischemic stroke, and 28 age-matched healthy control participants underwent corneal confocal microscopy to quantify corneal nerve fiber density, corneal nerve branch density, and corneal nerve fiber length. RESULTS There was a significant reduction in corneal nerve fiber density, corneal nerve branch density, and corneal nerve fiber length in stroke patients with normal glucose tolerance (P<0.001, P<0.001, P<0.001), impaired glucose tolerance (P=0.004, P<0.001, P=0.002), and type 2 diabetes mellitus (P<0.001, P<0.001, P<0.001) compared with controls. HbA1c and triglycerides correlated with corneal nerve fiber density (r=-0.187, P=0.03; r=-0.229 P=0.01), corneal nerve fiber length (r=-0.228, P=0.009; r=-0.285; P=0.001), and corneal nerve branch density (r=-0.187, P=0.033; r=-0.229, P=0.01). Multiple linear regression showed no independent associations between corneal nerve fiber density, corneal nerve branch density, and corneal nerve fiber length and relevant risk factors for stroke. CONCLUSIONS Corneal confocal microscopy is a rapid noninvasive ophthalmic imaging technique that identifies corneal nerve fiber loss in patients with acute ischemic stroke.
Collapse
Affiliation(s)
- Adnan Khan
- From the Department of Medicine (A.K., G.P., I.N.P., N.A.T., R.A.M.) and Biostatistics, Epidemiology, and Biomathematics Research Core (S.R.D.), Weill Cornell Medicine-Qatar, Doha; Department of Neurology, Institute of Neurosciences, Hamad Medical Corporation, Doha, Qatar (N.A., S.K., Y.I., F.S., A.P., P.B., R.K., M.S., S.J., A.S.); and Stroke Program, Department of Neurology, University of Alberta, Edmonton, Canada (A.S.)
| | - Naveed Akhtar
- From the Department of Medicine (A.K., G.P., I.N.P., N.A.T., R.A.M.) and Biostatistics, Epidemiology, and Biomathematics Research Core (S.R.D.), Weill Cornell Medicine-Qatar, Doha; Department of Neurology, Institute of Neurosciences, Hamad Medical Corporation, Doha, Qatar (N.A., S.K., Y.I., F.S., A.P., P.B., R.K., M.S., S.J., A.S.); and Stroke Program, Department of Neurology, University of Alberta, Edmonton, Canada (A.S.)
| | - Saadat Kamran
- From the Department of Medicine (A.K., G.P., I.N.P., N.A.T., R.A.M.) and Biostatistics, Epidemiology, and Biomathematics Research Core (S.R.D.), Weill Cornell Medicine-Qatar, Doha; Department of Neurology, Institute of Neurosciences, Hamad Medical Corporation, Doha, Qatar (N.A., S.K., Y.I., F.S., A.P., P.B., R.K., M.S., S.J., A.S.); and Stroke Program, Department of Neurology, University of Alberta, Edmonton, Canada (A.S.)
| | - Georgios Ponirakis
- From the Department of Medicine (A.K., G.P., I.N.P., N.A.T., R.A.M.) and Biostatistics, Epidemiology, and Biomathematics Research Core (S.R.D.), Weill Cornell Medicine-Qatar, Doha; Department of Neurology, Institute of Neurosciences, Hamad Medical Corporation, Doha, Qatar (N.A., S.K., Y.I., F.S., A.P., P.B., R.K., M.S., S.J., A.S.); and Stroke Program, Department of Neurology, University of Alberta, Edmonton, Canada (A.S.)
| | - Ioannis N Petropoulos
- From the Department of Medicine (A.K., G.P., I.N.P., N.A.T., R.A.M.) and Biostatistics, Epidemiology, and Biomathematics Research Core (S.R.D.), Weill Cornell Medicine-Qatar, Doha; Department of Neurology, Institute of Neurosciences, Hamad Medical Corporation, Doha, Qatar (N.A., S.K., Y.I., F.S., A.P., P.B., R.K., M.S., S.J., A.S.); and Stroke Program, Department of Neurology, University of Alberta, Edmonton, Canada (A.S.)
| | - Nahel A Tunio
- From the Department of Medicine (A.K., G.P., I.N.P., N.A.T., R.A.M.) and Biostatistics, Epidemiology, and Biomathematics Research Core (S.R.D.), Weill Cornell Medicine-Qatar, Doha; Department of Neurology, Institute of Neurosciences, Hamad Medical Corporation, Doha, Qatar (N.A., S.K., Y.I., F.S., A.P., P.B., R.K., M.S., S.J., A.S.); and Stroke Program, Department of Neurology, University of Alberta, Edmonton, Canada (A.S.)
| | - Soha R Dargham
- From the Department of Medicine (A.K., G.P., I.N.P., N.A.T., R.A.M.) and Biostatistics, Epidemiology, and Biomathematics Research Core (S.R.D.), Weill Cornell Medicine-Qatar, Doha; Department of Neurology, Institute of Neurosciences, Hamad Medical Corporation, Doha, Qatar (N.A., S.K., Y.I., F.S., A.P., P.B., R.K., M.S., S.J., A.S.); and Stroke Program, Department of Neurology, University of Alberta, Edmonton, Canada (A.S.)
| | - Yahia Imam
- From the Department of Medicine (A.K., G.P., I.N.P., N.A.T., R.A.M.) and Biostatistics, Epidemiology, and Biomathematics Research Core (S.R.D.), Weill Cornell Medicine-Qatar, Doha; Department of Neurology, Institute of Neurosciences, Hamad Medical Corporation, Doha, Qatar (N.A., S.K., Y.I., F.S., A.P., P.B., R.K., M.S., S.J., A.S.); and Stroke Program, Department of Neurology, University of Alberta, Edmonton, Canada (A.S.)
| | - Faheem Sartaj
- From the Department of Medicine (A.K., G.P., I.N.P., N.A.T., R.A.M.) and Biostatistics, Epidemiology, and Biomathematics Research Core (S.R.D.), Weill Cornell Medicine-Qatar, Doha; Department of Neurology, Institute of Neurosciences, Hamad Medical Corporation, Doha, Qatar (N.A., S.K., Y.I., F.S., A.P., P.B., R.K., M.S., S.J., A.S.); and Stroke Program, Department of Neurology, University of Alberta, Edmonton, Canada (A.S.)
| | - Aijaz Parray
- From the Department of Medicine (A.K., G.P., I.N.P., N.A.T., R.A.M.) and Biostatistics, Epidemiology, and Biomathematics Research Core (S.R.D.), Weill Cornell Medicine-Qatar, Doha; Department of Neurology, Institute of Neurosciences, Hamad Medical Corporation, Doha, Qatar (N.A., S.K., Y.I., F.S., A.P., P.B., R.K., M.S., S.J., A.S.); and Stroke Program, Department of Neurology, University of Alberta, Edmonton, Canada (A.S.)
| | - Paula Bourke
- From the Department of Medicine (A.K., G.P., I.N.P., N.A.T., R.A.M.) and Biostatistics, Epidemiology, and Biomathematics Research Core (S.R.D.), Weill Cornell Medicine-Qatar, Doha; Department of Neurology, Institute of Neurosciences, Hamad Medical Corporation, Doha, Qatar (N.A., S.K., Y.I., F.S., A.P., P.B., R.K., M.S., S.J., A.S.); and Stroke Program, Department of Neurology, University of Alberta, Edmonton, Canada (A.S.)
| | - Rabia Khan
- From the Department of Medicine (A.K., G.P., I.N.P., N.A.T., R.A.M.) and Biostatistics, Epidemiology, and Biomathematics Research Core (S.R.D.), Weill Cornell Medicine-Qatar, Doha; Department of Neurology, Institute of Neurosciences, Hamad Medical Corporation, Doha, Qatar (N.A., S.K., Y.I., F.S., A.P., P.B., R.K., M.S., S.J., A.S.); and Stroke Program, Department of Neurology, University of Alberta, Edmonton, Canada (A.S.)
| | - Mark Santos
- From the Department of Medicine (A.K., G.P., I.N.P., N.A.T., R.A.M.) and Biostatistics, Epidemiology, and Biomathematics Research Core (S.R.D.), Weill Cornell Medicine-Qatar, Doha; Department of Neurology, Institute of Neurosciences, Hamad Medical Corporation, Doha, Qatar (N.A., S.K., Y.I., F.S., A.P., P.B., R.K., M.S., S.J., A.S.); and Stroke Program, Department of Neurology, University of Alberta, Edmonton, Canada (A.S.)
| | - Sujatha Joseph
- From the Department of Medicine (A.K., G.P., I.N.P., N.A.T., R.A.M.) and Biostatistics, Epidemiology, and Biomathematics Research Core (S.R.D.), Weill Cornell Medicine-Qatar, Doha; Department of Neurology, Institute of Neurosciences, Hamad Medical Corporation, Doha, Qatar (N.A., S.K., Y.I., F.S., A.P., P.B., R.K., M.S., S.J., A.S.); and Stroke Program, Department of Neurology, University of Alberta, Edmonton, Canada (A.S.)
| | - Ashfaq Shuaib
- From the Department of Medicine (A.K., G.P., I.N.P., N.A.T., R.A.M.) and Biostatistics, Epidemiology, and Biomathematics Research Core (S.R.D.), Weill Cornell Medicine-Qatar, Doha; Department of Neurology, Institute of Neurosciences, Hamad Medical Corporation, Doha, Qatar (N.A., S.K., Y.I., F.S., A.P., P.B., R.K., M.S., S.J., A.S.); and Stroke Program, Department of Neurology, University of Alberta, Edmonton, Canada (A.S.)
| | - Rayaz A Malik
- From the Department of Medicine (A.K., G.P., I.N.P., N.A.T., R.A.M.) and Biostatistics, Epidemiology, and Biomathematics Research Core (S.R.D.), Weill Cornell Medicine-Qatar, Doha; Department of Neurology, Institute of Neurosciences, Hamad Medical Corporation, Doha, Qatar (N.A., S.K., Y.I., F.S., A.P., P.B., R.K., M.S., S.J., A.S.); and Stroke Program, Department of Neurology, University of Alberta, Edmonton, Canada (A.S.).
| |
Collapse
|